These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21463115)

  • 21. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
    Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
    Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers.
    Xu P; Jiang ZP; Zhang BK; Tu JY; Li HD
    Pharmacology; 2008; 82(3):221-7. PubMed ID: 18810246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
    Majid A; Lin TT; Best G; Fishlock K; Hewamana S; Pratt G; Yallop D; Buggins AG; Wagner S; Kennedy BJ; Miall F; Hills R; Devereux S; Oscier DG; Dyer MJ; Fegan C; Pepper C
    Leuk Res; 2011 Jun; 35(6):750-6. PubMed ID: 21093051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
    Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
    Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
    Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
    Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research progress on prognostic markers of chronic lymphocytic leukemia].
    Mao J; Mao ZR; Zhou R
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):250-6. PubMed ID: 20544986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.
    Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M
    Mol Biol Rep; 2014 Jan; 41(1):331-6. PubMed ID: 24213830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia.
    Wang YH; Zou ZJ; Liu L; Zhang LN; Fang C; Zhu DX; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1011-7. PubMed ID: 22362302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
    Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating prognostic information into treatment decisions in chronic lymphocytic leukemia.
    Jain N; Lamanna N
    Curr Oncol Rep; 2009 Sep; 11(5):353-9. PubMed ID: 19679010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases.
    Zou Y; Fan L; Xia Y; Miao Y; Wu W; Cao L; Wu J; Zhu H; Qiao C; Wang L; Xu W; Li J
    Cancer Med; 2018 May; 7(5):1689-1696. PubMed ID: 29573199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.
    Briani C; Visentin A; Salvalaggio A; Imbergamo S; Piazza F; Cacciavillani M; Campagnolo M; Frezzato F; Semenzato G; Trentin L
    Haematologica; 2017 Apr; 102(4):e140-e143. PubMed ID: 27927770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.